OSE Immunotherapeutics to Host Today a Virtual Immuno-Oncology R&D Day

R&D Day to highlight the Company’s strategy on its leading clinical programs and emerging firs-in-class portfolio in immuno-oncology;Presentations by leading clinicians to feature the latest data on Tedopi® and BI 765063.NANTES, France--(BUSINESS WIRE)--Regulatory News:OSE Immunotherapeutics (ISIN: FR0012127173; Mné...

Related Keywords

Italy ,France ,French ,Italian ,Thomas Guillot ,Philippe Cassier ,Florence Portejoie ,Guillaume Van Renterghem ,Benjamin Besse ,Darren Opland ,Nantes University Hospital ,Oncologist At Leon Berard Cancer Center Lyon ,Linkedin ,Lifesci Communications ,Twitter ,Boehringer Ingelheim ,Clinical Research At Gustave Roussy Villejuif ,Regulatory News ,Clinical Research ,Gustave Roussy ,Medical Oncologist ,Leon Berard Cancer Center ,Non Small Cell Lung Cancer ,Expansion Phase ,Universal Registration Document ,Lifesci Advisors ,